Caroline Litchfield $MRK SEC Form 4 Insider Trading

Caroline Litchfield has filed a total of 3 insider trades in $MRK since 2021. Their most recent trade was a sale of 41,997 shares, made on Feb 04, 2026. Their largest trade was a sale of 41,997 shares, made on Feb 04, 2026. We estimate that they now own 90,192 shares of $MRK, worth an estimated $7.1 million.

Insider Trading at $MRK

There have been a total of 103 insider trades reported at $MRK since 2021, with 18,241 shares purchased and 5.3 million shares sold. The most active insider traders in $MRK stock have been Kenneth C Frazier, Steven Mizell, and Joseph Romanelli. The most recent trade was a sale of 5,000 shares reported by David Michael Williams (EVP,Chief Info&Digital Officer), made on Feb 06, 2026.

$MRK Executives and Stock Owners with Insider Trades

• Kenneth C Frazier, Executive Chair

• Steven Mizell, EVP, Chief HR Officer

• Joseph Romanelli, President, Human Health Int?l

• Sanat Chattopadhyay, Exe V-P & Pres. MMD

• Richard R. Deluca, EVP&Pres, Merck Animal Heallth

• Johannes Jacobus Oosthuizen, President, U.S. Market

• Robert M Davis, Chairman, CEO & President

• Jennifer Zachary, EVP, General Counsel

• David Michael Williams, EVP,Chief Info&Digital Officer

• Rita A Karachun, Sr. VP Fince-Global Controller

• Robert M Davis, CEO & President

• Caroline Litchfield, EVP & CFO

• Dean Y Li, Executive VP & President, MRL

• Dalton E. Iii Smart, SVP Fin. - Global Controller

• Cristal N Downing, Chief Comm. & Public Afrs Ofcr

• Frank Clyburn, EVP & Pres ? Human Health

• Chirfi Guindo, Chief Marketing Officer

• Julie L. Gerberding, EVP, Chief Patient Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.